Announced the presentation of new positive interim data from the ongoing Phase I/II clinical trial evaluating the safety, tolerability, and efficacy of the Sernova Cell Pouch Transplant System ...
BioVaxys Technology Corp shares C.BIOV are trading unchanged at $0.06. Read: How AI and Quantum Computing Are Transforming Security in 2024 and Beyond As Silver Demand Climbs 19%, Mining Sector ...